UBS Group
GEN

UBS Group’s Genesis Healthcare, Inc. GEN Stock Holding History

UBS Group’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16,813
Closed -$8K – 9852
2020
Q4 		$8K Buy
16,813
+16,513
+5,504% +$8.34K ﹤0.01% 7660
2020
Q3 		$0 Sell
300
-175
-37% -$126 ﹤0.01% 8691
2020
Q2 		$0 Sell
475
-48,964
-99% -$39.4K ﹤0.01% 8595
2020
Q1 		$42K Sell
49,439
-59,037
-54% -$84.4K ﹤0.01% 5977
2019
Q4 		$178K Buy
108,476
+40,973
+61% +$61.5K ﹤0.01% 5677
2019
Q3 		$75K Buy
67,503
+45,741
+210% +$52.9K ﹤0.01% 5948
2019
Q2 		$27K Buy
21,762
+14,721
+209% +$18.7K ﹤0.01% 6421
2019
Q1 		$10K Buy
+7,041
New +$10.4K ﹤0.01% 6845
2018
Q4 		– Sell
-3,076
Closed -$4.56K – 8465
2018
Q3 		$4K Sell
3,076
-50
-2% -$79 ﹤0.01% 7604
2018
Q2 		$7K Sell
3,126
-26,272
-89% -$50.8K ﹤0.01% 7370
2018
Q1 		$44K Hold
29,398
– – ﹤0.01% 5817
2017
Q4 		$22K Buy
+29,398
New +$26.3K ﹤0.01% 6495
2017
Q2 		– Sell
-515
Closed -$1K – 8138
2017
Q1 		$1K Sell
515
-5,916
-92% -$21.3K ﹤0.01% 7499
2016
Q4 		$27K Sell
6,431
-6,141
-49% -$20.2K ﹤0.01% 6323
2016
Q3 		$34K Sell
12,572
-8,728
-41% -$20.1K ﹤0.01% 5825
2016
Q2 		$38K Buy
+21,300
New +$43.5K ﹤0.01% 5746
2015
Q4 		– Sell
-3,378
Closed -$21K – 8674
2015
Q3 		$21K Buy
3,378
+1,531
+83% +$10.4K ﹤0.01% 6659
2015
Q2 		$12K Buy
+1,847
New +$12.5K ﹤0.01% 7340

Other funds holding GEN

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

UBS Group's GEN Position: Q1 2021 in Review

UBS Group sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 16,813 shares — an estimated $8K sold.

UBS Group first reported a position in GEN in Q2 2015 and held it in 18 quarters. The position peaked at $178K in Q4 2019. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.

  • UBS Group reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
  • UBS Group sold 16,813 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $8K.
  • UBS Group first reported a position in Genesis Healthcare, Inc. in Q2 2015 and held it in 18 quarters.
  • UBS Group's Genesis Healthcare, Inc. position peaked at $178K in Q4 2019.
  • 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.

Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.